MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
41.16
+2.15 (5.51%)
At close: Jun 2, 2025, 4:00 PM
48.99
+7.83 (19.02%)
After-hours: Jun 2, 2025, 7:59 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $2.61 billion as of June 2, 2025. Its market cap has increased by 2.12% in one year.
Market Cap
2.61B
Enterprise Value
2.21B
1-Year Change
2.12%
Ranking
Category
Stock Price
$41.16
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $2.61B, an increase of 72,510.98%. That is a compound annual growth rate of 636.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 2.61B | -23.49% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |